Skip to main content

Dr. Courtney Coschi recognized with the Elizabeth Eisenhauer Early Drug Development Young Investigator Award

Dr. Courtney Coschi recognized with the Elizabeth Eisenhauer Early Drug Development Young Investigator Award

Dr. Courtney Coschi was recognized with the Elizabeth Eisenhauer Early Drug Development Young Investigator Award at the CCTG Spring Meeting. The award is presented to a new investigator who has worked at the CCTG Central Office, IND projects, or has contributed significantly to the conduct of an IND trial at a member centre.

“I am humbled and honoured to receive this award. Dr. Eisenhauer is an incredible leader both in Canada and globally with respect to excellence in clinical research and patient advocacy.  She inspires me to reflect on how I can impact patent care through my passion for early clinical trials research.  I am grateful to my family and so many colleagues who have provided support and mentorship as I navigate these early stages of my career.  My sincere gratitude to the CCTG for this award.”

Dr. Coschi is completing an Investigational New Drug Fellowship with the Canadian Cancer Trials Group and the Juravinski Cancer Centre.  She previously obtained her PhD in Biochemistry at Western University and is now a Postdoctoral Fellow through the Clinician Investigator Program at McMaster University, having been awarded a funded position.  Dr. Coschi completed her Medical Oncology training at McMaster University and was awarded a 2022 Canadian Fellow at ASCO trainee award.

Dr. Coschi has a longstanding passion for translational research, clinical trials and patient outreach.  She is co-chair of the Patient-centered Research and Early Clinical Trials Committee at the CCTG.  Courtney’s academic interests include improving patient quality of life and outcomes in early phase oncology clinical trials, engaging in translational research and validating a ctDNA liquid biopsy approach to improve equitable access to treatment options for lung cancer patients.